The Cancer Drug Fraction of Metabolism Database

Liyan Hua, Chien Wei Chiang, Wang Cong, Jin Li, Xueying Wang, Lijun Cheng, Weixing Feng, Sara Quinney, Lei Wang, Lang Li

Research output: Contribution to journalArticle

Abstract

This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the US Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate-depletion and metabolite-formation data from publicly available in vitro selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an in vitro drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios > 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 drug–drug interaction pairs.

Original languageEnglish (US)
Pages (from-to)511-519
Number of pages9
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume8
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

Metabolism
Drug interactions
Cancer
Drugs
Databases
Cytochrome P-450 Enzyme System
Drug Interactions
Pharmaceutical Preparations
Enzyme inhibition
Neoplasms
Metabolites
Interaction
United States Food and Drug Administration
Isoenzymes
Substrates
Prediction
Depletion
Enzymes
Substrate
In Vitro Techniques

ASJC Scopus subject areas

  • Modeling and Simulation
  • Pharmacology (medical)

Cite this

Hua, L., Chiang, C. W., Cong, W., Li, J., Wang, X., Cheng, L., ... Li, L. (2019). The Cancer Drug Fraction of Metabolism Database. CPT: Pharmacometrics and Systems Pharmacology, 8(7), 511-519. https://doi.org/10.1002/psp4.12417

The Cancer Drug Fraction of Metabolism Database. / Hua, Liyan; Chiang, Chien Wei; Cong, Wang; Li, Jin; Wang, Xueying; Cheng, Lijun; Feng, Weixing; Quinney, Sara; Wang, Lei; Li, Lang.

In: CPT: Pharmacometrics and Systems Pharmacology, Vol. 8, No. 7, 01.07.2019, p. 511-519.

Research output: Contribution to journalArticle

Hua, L, Chiang, CW, Cong, W, Li, J, Wang, X, Cheng, L, Feng, W, Quinney, S, Wang, L & Li, L 2019, 'The Cancer Drug Fraction of Metabolism Database', CPT: Pharmacometrics and Systems Pharmacology, vol. 8, no. 7, pp. 511-519. https://doi.org/10.1002/psp4.12417
Hua L, Chiang CW, Cong W, Li J, Wang X, Cheng L et al. The Cancer Drug Fraction of Metabolism Database. CPT: Pharmacometrics and Systems Pharmacology. 2019 Jul 1;8(7):511-519. https://doi.org/10.1002/psp4.12417
Hua, Liyan ; Chiang, Chien Wei ; Cong, Wang ; Li, Jin ; Wang, Xueying ; Cheng, Lijun ; Feng, Weixing ; Quinney, Sara ; Wang, Lei ; Li, Lang. / The Cancer Drug Fraction of Metabolism Database. In: CPT: Pharmacometrics and Systems Pharmacology. 2019 ; Vol. 8, No. 7. pp. 511-519.
@article{68121c49b48b4f918f35d8ce7a220e5c,
title = "The Cancer Drug Fraction of Metabolism Database",
abstract = "This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the US Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate-depletion and metabolite-formation data from publicly available in vitro selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an in vitro drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios > 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 drug–drug interaction pairs.",
author = "Liyan Hua and Chiang, {Chien Wei} and Wang Cong and Jin Li and Xueying Wang and Lijun Cheng and Weixing Feng and Sara Quinney and Lei Wang and Lang Li",
year = "2019",
month = "7",
day = "1",
doi = "10.1002/psp4.12417",
language = "English (US)",
volume = "8",
pages = "511--519",
journal = "CPT: Pharmacometrics and Systems Pharmacology",
issn = "2163-8306",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - The Cancer Drug Fraction of Metabolism Database

AU - Hua, Liyan

AU - Chiang, Chien Wei

AU - Cong, Wang

AU - Li, Jin

AU - Wang, Xueying

AU - Cheng, Lijun

AU - Feng, Weixing

AU - Quinney, Sara

AU - Wang, Lei

AU - Li, Lang

PY - 2019/7/1

Y1 - 2019/7/1

N2 - This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the US Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate-depletion and metabolite-formation data from publicly available in vitro selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an in vitro drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios > 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 drug–drug interaction pairs.

AB - This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the US Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate-depletion and metabolite-formation data from publicly available in vitro selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an in vitro drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios > 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 drug–drug interaction pairs.

UR - http://www.scopus.com/inward/record.url?scp=85069753326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069753326&partnerID=8YFLogxK

U2 - 10.1002/psp4.12417

DO - 10.1002/psp4.12417

M3 - Article

VL - 8

SP - 511

EP - 519

JO - CPT: Pharmacometrics and Systems Pharmacology

JF - CPT: Pharmacometrics and Systems Pharmacology

SN - 2163-8306

IS - 7

ER -